QuidelOrtho (NASDAQ:QDEL) Given New $25.00 Price Target at JPMorgan Chase & Co.
QuidelOrtho (NASDAQ:QDEL – Get Free Report) had its price objective reduced by research analysts at JPMorgan Chase & Co. from $38.00 to $25.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 2.21% […]
QuidelOrtho (NASDAQ:QDEL – Get Free Report) had its price objective reduced by research analysts at JPMorgan Chase & Co. from $38.00 to $25.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 2.21% […]
